GDNF and Parkinson disease: Whereas the use of viral vectors like lentiviral vectors for overexpressing GDNF is more common and succeeded in improving PD clinical symptoms of PD rats [35], SB transposons have certain advantages including faster and cheaper production under good manufacturing practices, increased biosafety, and low immunogenicity [36].